Morgan Stanley analyst Michael Cyprys downgraded MarketAxess (MKTX) to Equal Weight from Overweight with a price target of $209, down from $247. The firm believes a “benign” credit outlook and strong backdrop for new issuances into 2026 will likely weigh on MarketAxess’ market share. The firm sees a slower revenue and earnings growth profile for the company over the next years. In addition, MarketAxess’ newer protocols and initiatives may take longer to gain traction, adds Morgan Stanley.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKTX:
- MarketAxess price target raised to $198 from $194 at Keefe Bruyette
- MarketAxess price target raised to $188 from $186 at Barclays
- MarketAxess Holdings: Strong Performance and Growth Potential Amid Challenging Conditions
- MarketAxess Holdings: Positioned for Growth Amid Volatility and Strategic Initiatives
- MarketAxess Earnings Call: Growth Amid Challenges